Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference25 articles.
1. Marken P.A., Haykal R.F., Fisher J.N. Management of psychotropic-induced hyperprolactinemia. Clin. Pharmacol. 1992, 11: 851–856.
2. Dickson R.A., Glazer W.M. Neuroleptic-induced hyperprolactinemia. Schizophr. Res. 1999, 35: (Suppl.), S75–S86.
3. Marder S.R. Clinical experience with risperidone. J. Clin. Psychiatry 1996, 57: 57–61.
4. Huang M.L., Van Peer A., Woestenborghs R., De Coster R., Heykants J., Jansen A.I., Zylick 3. Z., Visscher H.W., Jonkman J.H.G. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clin. Pharmacol. Ther. 1993, 54: 257–268.
5. Shiwach R.S., Carmody T.J. Prolactogenic effects of risperidone in male patientsa preliminary study. Acta Psychiatr. Scand. 1998, 98: 81–83.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献